# EDGAR Filing Document

**Accession Number:** 0001733999
**File Stem:** 0001315863-25-000576
**Filing Date:** 2025-8
**Character Count:** 34293
**Document Hash:** 01a1cc21633c9debb1a5f83194dd0907
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001315863-25-000576.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001315863-25-000576

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 5

**FILED AS OF DATE**: 20250808

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Core Scientific, Inc.
- **CENTRAL INDEX KEY:** 0001733999

**ORGANIZATION NAME:**
- **EIN:** 823805526
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95028
- **FILM NUMBER:** 251196364

**BUSINESS ADDRESS:**
- **STREET 1:** 2800 NORTHUP WAY
- **STREET 2:** SUITE 220
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004
- **BUSINESS PHONE:** 424-377-1000

**MAIL ADDRESS:**
- **STREET 1:** 2800 NORTHUP WAY
- **STREET 2:** SUITE 220
- **CITY:** BELLEVUE
- **STATE:** WA
- **ZIP:** 98004

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MineCo Holdings Inc.
- **DATE OF NAME CHANGE:** 20180309
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Two Seas Capital LP
- **CENTRAL INDEX KEY:** 0001823138

**ORGANIZATION NAME:**
- **EIN:** 843799363
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 32 ELM PLACE, 3RD FLOOR
- **CITY:** RYE
- **STATE:** NY
- **ZIP:** 10580
- **BUSINESS PHONE:** 917.536.6028

**MAIL ADDRESS:**
- **STREET 1:** 32 ELM PLACE, 3RD FLOOR
- **CITY:** RYE
- **STATE:** NY
- **ZIP:** 10580

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Kairos Capital Management LP
- **DATE OF NAME CHANGE:** 20200831

## Exhibit 99.1

#### Exhibit 99.1
JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Stock, par value $0.00001 per share, of Core Scientific, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.

EXECUTED as of this 8th day of August, 2025.

---

| | |
|:---|:---|
| **TWO SEAS CAPITAL LP** | **TWO SEAS CAPITAL LP** |
| By: | Two Seas Capital GP LLC, its general partner |
| By: | /s/ Sina Toussi <br>|
| Name: | Sina Toussi |
| Title: | Managing Member |
| **TWO SEAS CAPITAL GP LLC** | **TWO SEAS CAPITAL GP LLC** |
| By: | /s/ Sina Toussi <br>|
| Name: | Sina Toussi |
| Title: | Managing Member <br>|
| **SINA TOUSSI** | **SINA TOUSSI** |
| By: | /s/ Sina Toussi <br>|

---

## Exhibit 99.1

Please see attached PDF<br>

## Exhibit 99.3

#### TRANSACTIONS
The following table sets forth all transactions by the Reporting Persons (on behalf of the Funds or Accounts) with respect to the securities of Core Scientific, Inc. effected in the last 60 days, inclusive of any transactions effected through 4:00 p.m., New York City time, on August 7, 2025. Except as otherwise noted below, all such transactions were purchases or sales of securities of Core Scientific, Inc. effected in the open market, and the table excludes commissions paid in per share prices.

#### TWO SEAS GLOBAL (MASTER) FUND LP

---

| | | | |
|:---|:---|:---|:---|
| Type of Security | Amount Purchased/(Sold) | Price Per Security ($) or Contract\* | Date of Purchase/Sale |
| Call Option (Exercise Price $15, Expiration 01/16/26) | 34,000 contracts relating to 3,400,000 | 2.089 | 6/9/2025 |
| Call Option (Exercise Price $21, Expiration 01/16/26) | (34000) contracts relating to (3400000) | 1.010 | 6/9/2025 |
| Call Option (Exercise Price $10, Expiration 06/20/25) | (8365) contracts relating to (836500) | 2.150 | 6/9/2025 |
| Common Stock | (250000) | 12.700 (1) | 6/10/2025 |
| Common Stock | 100000 | 11.700 | 6/17/2025 |
| Common Stock | 120000 | 11.810 | 6/17/2025 |
| Common Stock | 200000 | 15.292 (2) | 6/26/2025 |
| Common Stock | (500000) | 16.270 (3) | 6/26/2025 |
| Common Stock | (500000) | 16.321 (4) | 6/26/2025 |
| Common Stock | (250000) | 16.428 (5) | 6/26/2025 |
| Common Stock | (7032) | 16.515 (6) | 6/26/2025 |
| Warrant | 56130 | 9.571 (7) | 6/26/2025 |
| Warrant | 24107 | 15.568 (8) | 6/26/2025 |
| Common Stock | 250000 | 16.413 (9) | 6/27/2025 |
| Common Stock | (250000) | 17.100 | 6/27/2025 |
| Common Stock | (12532) | 17.544 (10) | 6/27/2025 |
| Common Stock | (500000) | 17.027 (11) | 6/30/2025 |
| Common Stock | (50000) | 17.100 | 6/30/2025 |
| Common Stock | (400000) | 17.450 | 7/2/2025 |
| Call Option (Exercise Price $21, Expiration 01/16/26) | 17,000 contracts relating to 1,700,000 shares | 2.687 | 7/3/2025 |
| Common Stock | 250000 | 13.850 (12) | 7/7/2025 |
| Common Stock | 250000 | 14.985 (13) | 7/7/2025 |
| Common Stock | 250000 | 13.845 | 7/8/2025 |
| Common Stock | 150000 | 14.005 | 7/8/2025 |
| Common Stock | 100000 | 14.008 | 7/8/2025 |
| Common Stock | 18679 | 13.298 (14) | 7/9/2025 |
| Common Stock | 100000 | 13.400 | 7/9/2025 |
| Common Stock | 50000 | 13.400 (15) | 7/9/2025 |
| Common Stock | 100000 | 13.520 (16) | 7/9/2025 |
| Common Stock | 100000 | 13.589 (17) | 7/9/2025 |
| Common Stock | 100000 | 13.592 (18) | 7/9/2025 |
| Common Stock | 100000 | 13.600 (19) | 7/9/2025 |
| Common Stock | 250000 | 13.370 (20) | 7/10/2025 |
| Common Stock | 100000 | 13.600 | 7/10/2025 |
| Common Stock | 150000 | 13.700 (21) | 7/10/2025 |
| Common Stock | 250000 | 12.513 (22) | 7/11/2025 |
| Common Stock | 250000 | 12.632 (23) | 7/11/2025 |
| Common Stock | (200000) | 13.549 (24) | 7/14/2025 |
| Warrant | (46839) | 7.489 (25) | 7/14/2025 |
| Common Stock | 200000 | 13.917 (26) | 7/16/2025 |
| Common Stock | 200000 | 13.469 (27) | 7/17/2025 |
| Common Stock | 200000 | 13.108 (28) | 7/18/2025 |
| Common Stock | 200000 | 13.265 (29) | 7/22/2025 |
| Common Stock | 250000 | 13.672 (30) | 7/24/2025 |
| Common Stock | (1000000) | 13.690 | 7/24/2025 |
| Common Stock | 93084 | 13.745 (31) | 7/25/2025 |
| Common Stock | 300000 | 13.612 | 7/28/2025 |
| Common Stock | (46666) | 13.500 | 7/31/2025 |
| Common Stock | 60000 | 13.560 | 7/31/2025 |
| Common Stock | 50000 | 13.578 (32) | 7/31/2025 |
| Common Stock | 200000 | 12.820 | 8/1/2025 |
| Common Stock | 14000 | 13.000 | 8/1/2025 |
| Call Option<br> (Exercise Price $13.5, Expiration 08/08/25) | 5,250 contracts relating to 525,000 shares | 0.464 | 8/4/2025 |
| Common Stock | 500000 | 14.080 | 8/5/2025 |
| Common Stock | 458300 | 13.970 | 8/6/2025 |
| Call Option<br> (Exercise Price $14, Expiration 08/08/25) | 6,362 contracts relating to 636,200 shares | 0.490 | 8/6/2025 |

---

#### TWO SEAS STRATEGIC FUND

---

| | | | |
|:---|:---|:---|:---|
| Type of Security | Amount Purchased/(Sold) | Price Per Security ($) or Contract\* | Date of Purchase/Sale |
| Common Stock | 100000 | 13.011 (33) | 7/30/2025 |
| Common Stock | 40000 | 13.560 | 7/31/2025 |
| Common Stock | 50000 | 13.578 (34) | 7/31/2025 |
| Common Stock | 86000 | 13.000 | 8/1/2025 |
| Common Stock | 100000 | 12.800 | 8/4/2025 |
| Common Stock | 100000 | 12.800 | 8/4/2025 |
| Common Stock | 360136 | 12.885 (35) | 8/4/2025 |
| Common Stock | 200000 | 12.890 | 8/4/2025 |
| Common Stock | 200000 | 12.910 | 8/4/2025 |
| Common Stock | 105607 | 13.246 (36) | 8/4/2025 |
| Common Stock | 121000 | 13.350 | 8/4/2025 |
| Common Stock | 100000 | 13.430 | 8/4/2025 |
| Common Stock | (20500) | 13.470 | 8/4/2025 |
| Call Option<br> (Exercise Price $13.5, Expiration 08/08/25) | 5,250 contracts relating to 525,000 shares | 0.464 | 8/4/2025 |
| Common Stock | 57440 | 13.789 (37) | 8/5/2025 |
| Common Stock | 100000 | 13.940 | 8/5/2025 |
| Common Stock | 23669 | 13.900 | 8/6/2025 |
| Common Stock | 39173 | 13.960 | 8/6/2025 |
| Common Stock | 54676 | 13.980 | 8/6/2025 |
| Common Stock | 117518 | 13.990 | 8/6/2025 |
| Call Option<br> (Exercise Price $14, Expiration 08/08/25) | 4,984 contracts relating to 498,400 shares | 0.490 | 8/6/2025 |
| Common Stock | 78284 | 14.299 (38) | 8/7/2025 |
| Common Stock | 78284 | 14.498 (39) | 8/7/2025 |

---

#### MANAGED ACCOUNTS

---

| | | | |
|:---|:---|:---|:---|
| Type of Security | Amount Purchased/(Sold) | Price Per Security ($) or Contract\* | Date of Purchase/Sale |
| Common Stock | 70000 | 13.900 | 8/6/2025 |
| Common Stock | 70000 | 13.900 | 8/6/2025 |
| Common Stock | 53432 | 13.900 | 8/6/2025 |
| Common Stock | 30000 | 13.900 | 8/6/2025 |
| Common Stock | 30000 | 13.900 | 8/6/2025 |
| Common Stock | 22899 | 13.900 | 8/6/2025 |
| Common Stock | 70000 | 13.950 | 8/6/2025 |
| Common Stock | 30000 | 13.950 | 8/6/2025 |
| Common Stock | 7580 | 13.960 | 8/6/2025 |
| Common Stock | 3247 | 13.960 | 8/6/2025 |
| Common Stock | 10579 | 13.980 | 8/6/2025 |
| Common Stock | 4534 | 13.980 | 8/6/2025 |
| Common Stock | 22738 | 13.990 | 8/6/2025 |
| Common Stock | 9744 | 13.990 | 8/6/2025 |
| Common Stock | 70000 | 13.999 (40) | 8/6/2025 |
| Common Stock | 30000 | 13.999 (41) | 8/6/2025 |
| Call Option<br> (Exercise Price $14, Expiration 08/08/25) | 965 contracts relating to 96,500 shares | 0.490 | 8/6/2025 |
| Call Option<br> (Exercise Price $14, Expiration 08/08/25) | 412 contracts relating to 41,200 shares | 0.490 | 8/6/2025 |
| Common Stock | 15201 | 14.299 (42) | 8/7/2025 |
| Common Stock | 6515 | 14.299 (43) | 8/7/2025 |
| Common Stock | 15201 | 14.498 (44) | 8/7/2025 |
| Common Stock | 6515 | 14.498 (45) | 8/7/2025 |

---

\*Prices reflected on a per share basis. Each option is subject to a 100 contract multiplier.

(1) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.700 to $12.710, inclusive. The reporting persons undertake to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in footnotes (1) – (45).

(2) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.580 to $16.130, inclusive.

(3) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.645 to $16.837, inclusive.

(4) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.290 to $16.415, inclusive.

(5) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.250 to $16.665, inclusive.

(6) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.500 to $16.530, inclusive.

(7) The sale price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.500 to $10.150, inclusive.

(8) The sale price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.450 to $16.500, inclusive.

(9) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.250 to $16.500, inclusive.

(10) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.500 to $17.620, inclusive.

(11) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.000 to $17.145, inclusive.

(12) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.800 to $13.900, inclusive.

(13) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.850 to $15.000, inclusive.

(14) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.278 to $13.400, inclusive.

(15) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.395 to $13.400, inclusive.

(16) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.515 to $13.550, inclusive.

(17) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.535 to $13.600, inclusive.

(18) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.535 to $13.600, inclusive.

(19) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.595 to $13.600, inclusive.

(20) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.110 to $13.790, inclusive.

(21) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.690 to $13.700, inclusive.

(22) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.425 to $12.590, inclusive.

(23) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.440 to $12.900, inclusive.

(24) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.540 to $13.570, inclusive.

(25) The purchase price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.450 to $7.515, inclusive.

(26) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.850 to $13.945, inclusive.

(27) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.435 to $13.525, inclusive.

(28) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.055 to $13.120, inclusive.

(29) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.130 to $13.300, inclusive.

(30) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.590 to $13.750, inclusive.

(31) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.730 to $13.750, inclusive.

(32) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.520 to $13.650, inclusive.

(33) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.720 to $13.200, inclusive.

(34) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.520 to $13.650, inclusive.

(35) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.860 to $12.890, inclusive.

(36) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.065 to $13.425, inclusive.

(37) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.405 to $14.000, inclusive.

(38) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.290 to $14.300, inclusive.

(39) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.450 to $14.499, inclusive.

(40) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.880 to $14.000, inclusive.

(41) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.880 to $14.000, inclusive.

(42) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.290 to $14.300, inclusive.

(43) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.290 to $14.300, inclusive.

(44) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.450 to $14.499, inclusive.

(45) The purchase price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.450 to $14.499, inclusive.

### Attached PDF Documents

**Attachment 1:** `ex99_2.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Core Scientific, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.00001 per share**

*(Title of Class of Securities)*

**21874A106**

*(CUSIP Number)*

**Lawrence V. Palermo**<br>Two Seas Capital LP<br>32 Elm Place, 3rd Floor<br>Rye NY 10580<br>(646) 420-4504

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/07/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **21874A106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Two Seas Capital LP** | Name of reporting person<br>**Two Seas Capital LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**19122842.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**19122842.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19122842.00** | Aggregate amount beneficially owned by each reporting person<br>**19122842.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.3%** | Percent of class represented by amount in Row (11)<br>**6.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **21874A106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Two Seas Capital GP LLC** | Name of reporting person<br>**Two Seas Capital GP LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**19122842.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**19122842.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19122842.00** | Aggregate amount beneficially owned by each reporting person<br>**19122842.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.3%** | Percent of class represented by amount in Row (11)<br>**6.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

| **CUSIP No.** | **21874A106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Sina Toussi** | Name of reporting person<br>**Sina Toussi** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**19122842.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**19122842.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**19122842.00** | Aggregate amount beneficially owned by each reporting person<br>**19122842.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.3%** | Percent of class represented by amount in Row (11)<br>**6.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.00001 per share

**(b) Name of Issuer:**
Core Scientific, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
838 Walker Road, 21-2105, DOVER, DE, 19904

Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

**Item 4. Purpose of Transaction**

The Reporting Persons acquired the securities reported herein for investment purposes in the ordinary course of business. The Reporting Persons acquired such securities because they believed that such securities, when purchased, represented an attractive investment opportunity.

On July 7, 2025, the Issuer, CoreWeave, Inc., a Delaware corporation ("CoreWeave"), and Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave ("Merger Sub"), entered into an Agreement and Plan of Merger (the "Merger Agreement"). The Merger Agreement provides, upon the terms and subject to the conditions set forth therein, for a merger between Merger Sub and the Issuer, with the Issuer surviving as a wholly owned subsidiary of CoreWeave.

On August 7, 2025, TSC issued a press release containing an open letter to the Issuer's shareholders (the "August 7 Letter") expressing its intent to vote against adoption of the Merger Agreement and the reasons therefor at the upcoming special meeting of stockholders of the Issuer (the "Special Meeting"), a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The Reporting Persons intend to solicit proxies against the Issuer's proposal to adopt the Merger Agreement at the Special Meeting and also intend to file a proxy statement in connection with the Special Meeting, if and when it is scheduled.

The foregoing description of the August 7 Letter does not purport to be complete and is qualified in its entirety by reference to the full text of the August 7 Letter, which is filed as Exhibit 99.2 and is incorporated herein by reference.

The Reporting Persons may have discussions with officers and directors of the Issuer in connection with the Reporting Persons' investment in the Issuer. The topics of these conversations may cover a range of issues, including those relating to the matters set forth in the August 7 Letter, the pending transaction involving CoreWeave, the Merger Agreement, the business of the Issuer, management, investor communications, operations, capital allocation, dividend policy, financial condition, mergers and acquisitions strategy, overall business strategy, executive compensation, corporate governance and environmental and social matters related to the Issuer's business and stakeholders. The Reporting Persons may also have similar conversations with other stockholders or other interested parties, such as industry analysts, existing or potential strategic partners or competitors, investment professionals and other investors and may exchange information with any such persons or the Issuer pursuant to appropriate confidentiality or similar agreements (which may contain customary standstill provisions). The Reporting Persons may at any time reconsider and change their intentions relating to the foregoing. Except as set forth herein, the Reporting Persons have no present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and depending upon various factors, including without limitation, the Issuer's financial position and strategic direction, the outcome of any discussions referenced above, overall market conditions, other investment opportunities available to them, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, may endeavor (i) to increase or decrease the Funds and Accounts' positions in the Issuer through, among other things, the purchase or sale of the shares of Common Stock and/or other equity, debt, derivative securities or other instruments that are convertible into such securities, or are based upon or relate to the value of such securities or the Issuer (collectively, "Securities") on the open market or in private transactions, including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) to enter into transactions that increase or hedge its economic exposure to the shares of Common Stock or other Securities without affecting the Reporting Persons' beneficial ownership of the Common Stock or other Securities.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Each of the Reporting Persons may be deemed to beneficially own 19,122,842 shares of Common Stock of the Issuer, which includes 313,646 issuable upon exercise of warrants and options to purchase 5,722,300 shares of Common Stock.  Such amount of beneficial ownership represents approximately 6.3% of the shares of Common Stock outstanding, based on 303,694,175 shares of Common Stock outstanding as of July 2, 2025, based on information disclosed in Exhibit 2.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission on July 7, 2025, plus 313,646 shares of Common Stock issuable upon the exercise of warrants held by the Funds.  The Funds and Accounts have delegated to TSC sole voting and investment power over the securities held by the Funds and Accounts pursuant to their respective Investment Management Agreements with TSC. As a result, each of TSC, TSC GP, as the general partner of TSC, and Mr. Toussi, as Chief Investment Officer of TSC and Managing Member of TSC GP, may be deemed to exercise voting and investment power over the securities of the Issuer directly held by the Funds and Accounts. The Funds and Accounts specifically disclaim beneficial ownership of the securities of the Issuer directly held by them by virtue of their inability to vote or dispose of such securities as a result of their respective Investment Management Agreements with TSC. The information in Item 3 regarding the securities held by the Funds and Accounts is incorporated herein by reference.

The options to purchase Common Stock consist of options to purchase 3,400,000 shares of Common Stock with an exercise price of $15 per share that expire on January 16, 2026, options to purchase 1,050,000 shares of Common Stock with an exercise price of $13.50 per share that expire on August 8, 2025, and options to purchase 1,272,300 shares of Common Stock with an exercise price of $14 per share that expire on August 8, 2025. Global Fund sold options to purchase 1,700,000 shares of Common Stock with an exercise price of $21 per share that expire on January 16, 2026.

Item 6 of this Schedule 13D is incorporated herein by reference

**(b)**
Items 7 through 10 of each of the cover pages of this Schedule 13D are incorporated herein by reference. The information in Item 3 regarding the securities held by the Funds and Accounts is incorporated herein by reference.

**(c)**
Transactions by the Reporting Persons (on behalf of the Funds and Accounts) effected during the past 60 days are set forth in Exhibit 99.3 and such information is incorporated herein by reference.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 5 of this Schedule 13D is incorporated herein by reference.

The Global Fund holds 289,539 warrants currently exercisable at an exercise price of $6.81 per share and expire on January 23, 2027.  The form of Warrant is incorporated by reference as Exhibit 99.4 and is incorporated herein by reference.

The Global Fund holds 24,107 warrants currently exercisable at an exercise price of $0.01 per share and expire on January 23, 2029.  The form of Warrant is incorporated by reference as Exhibit 99.5 and is incorporated herein by reference.

The Global Fund has entered into cash-settled swaps which represent economic exposure comparable to a notional interest in 500,000 shares of Common Stock (representing economic exposure comparable to approximately 0.2% of the outstanding Common Stock) with Jefferies Financial Products, LLC.  Under the terms of the swaps, (i) the Global Fund will be obligated to pay to the counterparty any negative price performance of the specified notional number of Common Stock subject to the swaps as of the expiration date of such swaps, plus interest rates set forth in the applicable contracts, and (ii) the counterparty will be obligated to pay the Global Fund any positive price performance of the specified notional number of Common Stock subject to the swaps as of the expiration date of the swaps.  All balances will be settled in cash. The swaps do not give the Reporting Persons or Funds direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparty thereto to acquire, hold, vote or dispose of any securities of the Issuer.  Accordingly, the Reporting Persons disclaim any beneficial ownership of any Common Stock that may be referenced in the swap contracts or Common Stock or other securities or financial instruments that may be held from time to time by any counterparty to the contracts.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Two Seas Capital LP

**Signature:** /s/ Sina Toussi

**Name/Title:** Sina Toussi/Managing Member of Two Seas Capital GP LLC, its general partner

**Date:** 08/08/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Two Seas Capital GP LLC

**Signature:** /s/ Sina Toussi

**Name/Title:** Sina Toussi/Managing Member

**Date:** 08/08/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Sina Toussi

**Signature:** /s/ Sina Toussi

**Name/Title:** Sina Toussi

**Date:** 08/08/2025